Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids
作者:Lucia Semelková、Petra Janošcová、Carlos Fernandes、Ghada Bouz、Ondřej Janďourek、Klára Konečná、Pavla Paterová、Lucie Navrátilová、Jiří Kuneš、Martin Doležal、Jan Zitko
DOI:10.3390/molecules22091491
日期:——
form, pyrazinoic acid, have been found. We have designed and prepared 3-(phenyl-carbamoyl)pyrazine-2-carboxylic acids as more lipophilic derivatives of pyrazinoic acid. We also prepared methyl and propyl derivatives as prodrugs with further increased lipophilicity. Antimycobacterial, antibacterial and antifungal growth inhibiting activity was investigated in all prepared compounds. 3-[(4-Nitrophenyl
吡嗪酰胺是一线抗结核药物,六十多年来一直被认为是结核病治疗的基本组成部分。长期以来,研究人员一直在研究其对结核分枝杆菌的影响,结果发现了吡嗪酰胺或其活性形式吡嗪酸的新潜在靶标。我们设计并制备了 3-(苯基-氨基甲酰基)吡嗪-2-羧酸作为吡嗪酸的亲脂性更强的衍生物。我们还制备了甲基和丙基衍生物作为具有进一步增加的亲脂性的前药。在所有制备的化合物中研究了抗分枝杆菌、抗菌和抗真菌生长抑制活性。3-[(4-硝基苯基)氨基甲酰基]吡嗪-2-羧酸 (16) 对结核分枝杆菌 H37Rv 具有高抗分枝杆菌活性,MIC = 1.56 μg·mL-1 (5 μM)。Propyl 3-[4-(trifluoromethyl)phenyl]carbamoyl}pyrazine-2-carboxylate (18a) 也显示出对结核分枝杆菌 H37Rv 的高抗分枝杆菌活性,MIC = 3.13 μg·mL-1。研